AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 190 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 2.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $742,000 | -37.4% | 37,100 | -39.0% | 0.01% | -40.0% |
| Q2 2018 | $1,186,000 | -10.3% | 60,800 | -7.3% | 0.01% | -16.7% |
| Q1 2018 | $1,322,000 | +99.4% | 65,600 | +31.2% | 0.01% | +100.0% |
| Q4 2017 | $663,000 | -46.8% | 50,000 | -26.0% | 0.01% | -50.0% |
| Q3 2017 | $1,247,000 | +108.5% | 67,600 | +108.0% | 0.01% | +100.0% |
| Q2 2017 | $598,000 | -18.4% | 32,500 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $733,000 | – | 32,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |